Page last updated: 2024-09-03

n,n-dimethylarginine and Heart Disease, Ischemic

n,n-dimethylarginine has been researched along with Heart Disease, Ischemic in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (36.36)	29.6817
2010's	5 (45.45)	24.3611
2020's	2 (18.18)	2.80

Authors

Authors	Studies
Burger, AL; Demyanets, S; Diedrich, A; Pezawas, T; Stojkovic, S; Wojta, J	1
Baião, DDS; da Silva, DVT; Paschoalin, VMF; Trindade, LR	1
Bache, RJ; Chen, Y; Fassett, JT; Hu, X; Li, J; Xu, X; Zhang, P; Zhu, G	1
Damaske, A; Fasola, F; Fineschi, M; Forconi, S; Gori, T; Jabs, A; Munzel, T; Muxel, S; Orphal, D; Parker, JD; Radmacher, MC; Schaefer, S; Wild, P	1
Dai, G; Deng, N; Guo, Y; Li, X; Wang, X; Wu, Y; Xu, Q; Zheng, P	1
Chung, MY; Hsu, CP; Lin, SJ; Lu, TM	1
Anderssohn, M; Böger, RH; Frey, N; Lüneburg, N; Lutz, M; Rosenberg, M; Schwedhelm, E; Zugck, C	1
Hedner, T; Hultberg, B; Jonasson, TF; Ohlin, H	1
Conci, E; Cooke, JP; Haubner, BJ; Metzler, B; Pachinger, O; Schwaighofer, J; Stocker, EM; Stühlinger, MC; Tsao, PS	1
Andreotti, F; Coluzzi, G; Marzo, F; Santucci, E	1
Cooke, JP; Losordo, DW	1

Reviews

2 review(s) available for n,n-dimethylarginine and Heart Disease, Ischemic

Article	Year
Increasing the Power of Polyphenols through Nanoencapsulation for Adjuvant Therapy against Cardiovascular Diseases. Molecules (Basel, Switzerland), 2021, Jul-30, Volume: 26, Issue:15 Topics: Antioxidant Response Elements; Antioxidants; Arginine; Cardiotonic Agents; Diabetes Mellitus; Drug Carriers; Drug Compounding; Dyslipidemias; Gene Expression Regulation; Humans; Hypertension; Myocardial Ischemia; Nanocapsules; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Polyphenols; Signal Transduction	2021
Peripheral hemorheological and vascular correlates of coronary blood flow. Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4 Topics: Arginine; Blood Flow Velocity; Chest Pain; Coronary Circulation; Diagnosis, Differential; Endothelium, Vascular; Female; Hemorheology; Humans; Hyperhomocysteinemia; Inflammation; Male; Microvessels; Myocardial Ischemia; Nitric Oxide; Platelet Activation; Syndrome; Vascular Resistance; Vasodilator Agents	2011

Article

Year

Increasing the Power of Polyphenols through Nanoencapsulation for Adjuvant Therapy against Cardiovascular Diseases.

Molecules (Basel, Switzerland), 2021, Jul-30, Volume: 26, Issue:15

Topics: Antioxidant Response Elements; Antioxidants; Arginine; Cardiotonic Agents; Diabetes Mellitus; Drug Carriers; Drug Compounding; Dyslipidemias; Gene Expression Regulation; Humans; Hypertension; Myocardial Ischemia; Nanocapsules; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Polyphenols; Signal Transduction

2021

Peripheral hemorheological and vascular correlates of coronary blood flow.

Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4

Topics: Arginine; Blood Flow Velocity; Chest Pain; Coronary Circulation; Diagnosis, Differential; Endothelium, Vascular; Female; Hemorheology; Humans; Hyperhomocysteinemia; Inflammation; Male; Microvessels; Myocardial Ischemia; Nitric Oxide; Platelet Activation; Syndrome; Vascular Resistance; Vasodilator Agents

2011

Trials

1 trial(s) available for n,n-dimethylarginine and Heart Disease, Ischemic

Article	Year
Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease. European journal of clinical investigation, 2003, Volume: 33, Issue:7 Topics: Adult; Arginine; Female; Folic Acid; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Ischemia; Nitric Oxide Synthase; Pyridoxine; Vitamin B 12	2003

Other Studies

8 other study(ies) available for n,n-dimethylarginine and Heart Disease, Ischemic

Article	Year
Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy - A prospective, controlled long-term study. Clinical biochemistry, 2020, Volume: 83 Topics: Aged; Arginine; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Case-Control Studies; Female; Heart Arrest; Humans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Risk Factors; Ventricular Dysfunction, Left	2020
Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression. Vascular medicine (London, England), 2017, Volume: 22, Issue:3 Topics: Amidohydrolases; Animals; Arginine; Cell Hypoxia; Cells, Cultured; Collateral Circulation; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Endothelial Cells; Humans; Interleukin-1beta; Myocardial Ischemia; Myocardium; Neovascularization, Physiologic; Nitric Oxide Synthase Type II; Protein-Arginine N-Methyltransferases; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Endothelial Growth Factor A	2017
Regulation of endothelial nitric oxide synthase and asymmetric dimethylarginine by matrine attenuates isoproterenol-induced acute myocardial injury in rats. The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:8 Topics: Alkaloids; Amidohydrolases; Animals; Arginine; Catechol O-Methyltransferase; Glycogen Synthase Kinases; Heart Ventricles; Isoproterenol; Male; Matrines; Myocardial Ischemia; Myocardium; Necrosis; Nitric Oxide Synthase Type III; Phosphorylation; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Quinolizines; Rats; Rats, Sprague-Dawley; Sophora	2012
Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure. Atherosclerosis, 2012, Volume: 225, Issue:2 Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, High Pressure Liquid; Coronary Angiography; Disease-Free Survival; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke Volume; Taiwan; Time Factors; Ultrasonography; Up-Regulation; Ventricular Function, Left	2012
The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy. Journal of cardiac failure, 2012, Volume: 18, Issue:12 Topics: Arginine; Biomarkers; Cardiomyopathies; Cardiomyopathy, Dilated; Chromatography, Liquid; Creatinine; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Severity of Illness Index; Tandem Mass Spectrometry	2012
Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury. Cardiovascular research, 2007, Jul-15, Volume: 75, Issue:2 Topics: Amidohydrolases; Animals; Arginine; Blotting, Western; Endothelium, Vascular; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxidase	2007
Asymmetric dimethylarginine and impaired cardiovascular healing. Journal of thrombosis and thrombolysis, 2009, Volume: 27, Issue:2 Topics: Apoptosis; Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Myocardial Ischemia; Nitric Oxide; Prognosis; Regeneration; Stem Cells; Treatment Outcome	2009
Nitric oxide and angiogenesis. Circulation, 2002, May-07, Volume: 105, Issue:18 Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Arginine; Arteriosclerosis; Coronary Circulation; Dogs; Endothelium, Vascular; Matrix Metalloproteinases; Myocardial Ischemia; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Plasminogen	2002